Schwarz Pharma' s Transdermal Parkinson's Patch Approved

Schwarz Pharma (SWTZY.PK) just announced that their Transdermal Parkinson's Patch, which delivers a measured dose of rotigotine, has been approved by the FDA. 87.62 % of the SCHWARZ PHARMA shares, which primarily trade in Germany, are owned by UCB NPV (UCBJF.PK) which primarily trades on the Euronext Brussels Exchange.